INTRODUCTION
============

The time at which renal replacement therapy (RRT) is initiated in patients with end-stage renal disease (ESRD) has greatly influenced the prognosis of patients, and various signs of protein-energy malnutrition in patients with ESRD are strong predictors of increased morbidity and mortality^[@b1-kjim-19-2-81-2]--[@b3-kjim-19-2-81-2])^. Absolute indications for the initiation of RRT include; pericardial effusion, pulmonary edema, uncontrolled hypertension, uremic encephalopathy, uremic neuropathy, metabolic acidosis, and uncontrolled bleeding tendency. Relative indications for the initiation of RRT include: poor appetite, anorexia, fatigue, general weakness, cognitive disorder, pruritus, and depressive mood^[@b4-kjim-19-2-81-2])^. However, there are currently no accurate guidelines for the initiation of RRT. Traditionally, most nephrologists usually start RRT on the basis of the observations of the uremic symptoms and changes in the laboratory parameters, such as serum creatinine concentration and/or glomerular filtration rate (GFR).

Because there are no accurate guidelines, it is difficult to decide the best time to initiate RRT in patients with higher BUN or serum creatinine levels, but without uremic symptoms, or patients with uremic symptoms, but lower BUN or serum creatinine levels^[@b5-kjim-19-2-81-2])^. Park et al. reported there was no correlation between the uremic symptoms and residual renal function (RRF) at the time of RRT initiation^[@b6-kjim-19-2-81-2])^. The urea clearance in patients with chronic renal failure (CRF) underestimates the GFR, but the creatinine clearance in patients with CRF overestimates the GFR^[@b4-kjim-19-2-81-2])^. Some investigators have suggested that the mean creatinine and urea clearances would be reasonable estimates of the GFR, at least in patients with low renal function levels. The serum creatinine levels are influenced by diet, age, gender, muscle mass, diabetes and race^[@b7-kjim-19-2-81-2])^. A few prospective studies have demonstrated no correlation between the biochemical indices, including BUN and serum creatinine, and the survival rate of patients with ESRD^[@b5-kjim-19-2-81-2],\ [@b8-kjim-19-2-81-2])^.

The DOQI guidelines suggest a weekly Kt/Vurea \< 2.0 or a normalized protein equivalent of nitrogen appearance (nPNA) \< 0.8 g/kg/day as objective indices for the initiation of RRT^[@b9-kjim-19-2-81-2])^. Thus, a *KP index* was formulated (weekly Kt/Vurea+2.5 × nPNA) × 1/2 using the above two clinically useful and objective indices for the determinatione of the best time to initiate RRT in patients with ESRD. The aims of this study were to evaluate the usefulness of the *KP index*, as an objective index for the determinatione of the best time to initiate RRT in patients with ESRD, and evaluate the correlations between the *KP index*, renal function indices, protein intake index, and nutritional indices.

MATERIALS AND METHODS
=====================

1. Subjects
-----------

A total of 186 patients with a weekly Kt/Vurea \< 3.0 were admitted to Soonchunhyang University Hospital in Bucheon, Korea, between February 1, 2001 and October 15, 2002. Age, gender, height, body weight, underlying renal disease, and 24-hour urine volume were recorded for all the subjects. Blood chemistries, including serum creatinine, BUN and serum albumin, and 24-hour urine chemistries, including protein, creatinine and urea nitrogen, were measured by standard techniques.

### 1) Renal function indices

The weekly total Kt/Vurea, creatinine clearance (Ccr) and urea nitrogen clearance were calculated in the urine collected over a 24-hour period. The residual renal function (RRF) was estimated as the mean renal urea and creatinine clearances. The urea volume distribution (Vurea) was calculated using the Watson equations^[@b10-kjim-19-2-81-2])^. $$\begin{array}{l}
{\text{Weekly~Kt}/\text{Vurea} = (\text{Kt}/\text{Vurea}) \times 7} \\
{\mspace{135mu} = \left\{ (\text{Uurea}/\text{BUN}) \times \text{Vu}/1000 \right\}/\text{Vurea} \times 7} \\
{\text{Weekly~creatinine~clearance}\,(L/\text{week}/1.73\, m^{2})} \\
{\mspace{135mu} = (\text{Ucr}/\text{Pcr}) \times \text{Vu}/1000 \times 7 \times 1.73/\text{BSA}} \\
{\text{Ccr }(\text{mL}/\text{min}/1.73m^{2}) = (\text{Ucr}/\text{Pcr}) \times \text{Vu}/1440 \times 1.73/\text{BSA}} \\
{\text{Curea }(\text{mL}/\text{min}) = (\text{Uurea}/\text{BUN}) \times \text{Vu}/1440} \\
{\text{RRF }(\text{mL}/\text{min}) = (\text{Ccr} + \text{Curea}) \times 1/2} \\
\end{array}$$

1.  Uurea: urine urea nitrogen concentration (mg/dL)

2.  Vu: urine volume (mL)

3.  Ucr: urine creatinine concentration (mg/dL)

4.  Per: plasma creatinine concentration (mg/dL)

5.  BSA: body surface area (m^2^)

6.  RRF: residual renal function

### 2) Protein intake index

The dietary protein intake was calculated from the protein equivalent of total nitrogen appearance (PNA), using the Bergström equation 2^[@b11-kjim-19-2-81-2])^. The nPNA was estimated as the PNA normalized to the standard body weight. $$\begin{array}{l}
{\text{Bergström~formula~}2\text{~nPNA}\,(\text{nPNA})\,(g/\text{kg}/\text{day})} \\
{\mspace{126mu} = (15.1 + 6.95 \times \text{UNA})/(V/0.58)} \\
\end{array}$$

1.  UNA: urea nitrogen appearance (g/day)

2.  V: the urea volume distribution by the Watson normogram^[@b10-kjim-19-2-81-2])^

### 3) Nutritional indices

The fat-free edema-free body mass (FFEFBM) was calculated from the creatinine kinetics^[@b11-kjim-19-2-81-2])^. The percent lean body mass (%LBM) was estimated as the FFEFBM normalized to a standard weight^[@b12-kjim-19-2-81-2])^. $$\begin{array}{l}
{\text{FFEFBM}\,(\text{kg}) = 0.029 \times \text{total~creatinine~product}\,(\text{mg}/\text{day}) + 7.38} \\
{\mspace{105mu} = 0.029 \times (24\text{Ucr} + 24\text{Gcr}) + 7.38} \\
\end{array}$$

1.  24Gcr (Gut creatinine) = 0.036×Pcr×body weight

2.  \% LBM (%) = FFEFBM/standard weight×100

3.  24 Ucr: 24 hours urine creatinine amount (mg/day)

4.  24 Gcr: 24 hours gut creatinine amount (mg/day)

### 4) KP index

The *KP index* was formulated, using the Kt/Vurea and nPNA, in an attempt to find a clinically useful and objective index for the determinatione of the adeguate time to initiate RRT in patients with ESRD. $$\mathit{KP}\,\mathit{index} = \ \left( {\text{weekly~Kt}/\text{Vurea} + 2.5 \times \text{nPNA}} \right) \times 1/2$$

2. Methods
----------

Patients with a weekly Kt/Vurea between 1.0 and 2.0, and being considered for RRT, were divided into two groups according to their *KP index*. The renal function indices, protein intake index, nutritional indices and incidence of initiation of RRT were compared between the two groups. The correlations between the *KP index*, renal function indices, protein intake index and nutritional indices were evaluated in all the patients. The incidences of initiation of RRT in the 1.5 \< Kt/Vurea \< 2.0 and 2.0 \< Kt/Vurea \< 2.5 groups were also compared, as were the incidences of initiation of RRT in the 1.5 \< *KP index* \< 2.0 and 2.0 \< *KP index* \< 2.5 groups.

3. Statistical Analysis
-----------------------

A statistical analysis was performed using the SPSS program. The student's *t*-test was used to compare the differences between the two groups, and the Pearson chi-square test to compare the incidences between the two groups. Pearson's correlation was used to estimate the correlation between two variables. The difference was considered significant when the *p* value was less than 0.05.

RESULTS
=======

1. Clinical Characteristics
---------------------------

Of the 186 patients, there were 94 males and 92 females, with a mean age of 56.1 ±14.7 years. In an analysis of the underlying disease, 82 patients were diabetics, 46 had chronic glomerulonephritis, 12 had hypertension, and 6 had polycystic kidney disease. Diabetes was the most common cause of chronic renal failure. The mean serum albumin, serum creatinine, weekly Kt/Vurea, nPNA, %LBM and *KP index* values were 3.24±0.86 g/dL, 6.67±3.40 mg/dL, 1.61±0.74, 0.92±0.30 g/kg/day, 45.9±13.2% and 1.95±0.67, respectively ([Table 1](#t1-kjim-19-2-81-2){ref-type="table"}).

2. Comparison of indices according to *KP index* in the patients with weekly Kt/Vurea index between 1.0 and 2.0
---------------------------------------------------------------------------------------------------------------

Of the 186 patients, 91 had a weekly Kt/Vurea between 1.0 and 2.0, with 54 and 37 having a *KP index* \< 2.0 and \> 2.0, respectively. The weekly Kt/Vurea, nPNA, %LBM in the *KP index* \< 2.0 and \> 2.0 groups were 1.37±0.24 vs. 1.71±0.20, 0.79±0.15 vs. 1.12±0.20 and 44.7±10.6 vs. 54.0±11.1, respectively, so were all significantly lower in the *KP index* \< 2.0 than the *KP index* \> 2.0 group (*p*\<0.001)([Table 2](#t2-kjim-19-2-81-2){ref-type="table"}). There were no significant differences between the two groups in relation to the serum albumin, serum creatinine, and FFEFBM, RRF, and 24-hour urine protein excretion ([Table 2](#t2-kjim-19-2-81-2){ref-type="table"}). The incidence of RRT in the *KP index* \< 2.0 group (26/54, 48.2%) was significantly higher than in the *KP index* \> 2.0 group (7/37, 18.9%) ([Table 3](#t3-kjim-19-2-81-2){ref-type="table"}).

3. Correlation matrix for indices of *KP index*, renal function, protein intake, and nutritional status in the all patients
---------------------------------------------------------------------------------------------------------------------------

There were significant correlations between the *KP index* and the weekly Kt/Vurea (*r*=0.896, *p*\<0.01), RRF (*r*=0.681, *p*\<0.01), cr (*r*=0.520, *p*\<0.01), nPNA (*r*=0.896, *p*\<0.01), %LBM (*r*=0.626, *p*\<0.01) ([Figure 1](#f1-kjim-19-2-81-2){ref-type="fig"}) and FFEFBM (r=0.485, *p*\<0.01). There was also a significant correlation between weekly Kt/Vurea and nPNA (*r*=0.605, *p*\<0.01) ([Figure 2](#f2-kjim-19-2-81-2){ref-type="fig"}, [Table 4](#t4-kjim-19-2-81-2){ref-type="table"}).

4. Comparison of incidence of RRT according to Kt/Vurea
-------------------------------------------------------

Of the 186 patients, 44 and 32 were included in the 1.5\<Kt/Vurea \<2.0 and 2.0\<Kt/Vurea \<2.5 groups, respectively, and the incidence of RRT was not significant between these two groups (11/44, 25.0% vs. 3/32, 9.4%)([Table 5](#t5-kjim-19-2-81-2){ref-type="table"}).

5. Comparison of incidence of RRT according to *KP index*
---------------------------------------------------------

Of the 186 patients, 55 and 59 were in the 1.5\<*KP index* \<2.0 and 2.0\<*KP index* \<2.5 groups, respectively, and the incidence of RRT was significantly higher than in the 2.0\<*KP index* \<2.5 group (8/59, 13.6%) ([Table 6](#t6-kjim-19-2-81-2){ref-type="table"}).

DISCUSSION
==========

There is still much controversy about the most suitable time to initiate RRT, in patients with ESRD, to increase the patient survival rate, improve the quality of life, and minimize other organ failures. The nutritional factors at the time of RRT initiation, in patients with ESRD, are strong predictors of increased morbidity and mortality^[@b1-kjim-19-2-81-2]--[@b3-kjim-19-2-81-2])^, and malnutrition is recognized as being common in patients with CRF. Kang et al. described that the biochemical indices, including serum albumin, prealbumin, creatinine, cholesterol, insulin like growth factor-1 (IGF-1), C-reactive protein (CRP) and abnormal acid-base metabolism, were useful in estimating the nutritional status of CAPD patients, and the serum albumin, IGF-1, transferrin, serum creatinine and prealbumin were significantly lower in their malnutrition group of CAPD patients^[@b13-kjim-19-2-81-2])^. Song et al. reported that biochemical abnormalities, including hypoalbuminemia (\<3.5 g/dL), hypocholesterolemia (\<130 mg/dL), and hypophosphatemia (\<5.0 mg/dL), were strong predictors of increased mortality during the early stages of RRT in hemodialysis patients^[@b3-kjim-19-2-81-2])^. These indices were continually lower during the first six months after hemodialysis. Several studies have reported that hypoalbuminemia during the early stages of RRT was the strongest predictor of patient survival rates^[@b2-kjim-19-2-81-2],\ [@b3-kjim-19-2-81-2])^. The nutritional status during the pre-dialysis period greatly influences the prognosis of patients with ESRD.

Hakim et al. recommended starting dialysis before revealing uremic side effects or uremic symptoms and before the malnutritional status had been confirmed. Their definition of malnutrition included a serum albumin level lower than 4.0 g/dL, dietary protein intake lower than 0.7 g/kg/day, weight loss, decreased muscle mass, and decreased serum transferrin levels^[@b4-kjim-19-2-81-2])^. Hertel et al. reported that starting RRT during the early stages of ESRD increased the serum albumin levels and raised the urea reduction rates by improving the nutritional status^[@b14-kjim-19-2-81-2])^. Controversially, Jamie et al. suggested there were no differences in long-term survival rates of patient with ESRD between groups started at an early or late stage^[@b15-kjim-19-2-81-2])^. Also, many studies reported the inappropriate decision to initiate of RRT in patients with ESRD caused clinical side effects and unexpected economical effects which consequently led to increased prevalence rates and medical expenses^[@b16-kjim-19-2-81-2]--[@b19-kjim-19-2-81-2])^.

The DOQI guidelines suggest a weekly Kt/Vurea\<2.0 or nPNA\<0.8 g/kg/day as objective indices for the initiatione of RRT, and in patients with a weekly Kt/Vurea lower than 2.0^[@b9-kjim-19-2-81-2])^, the GFR calculated by the urea and creatinine clearances was about 10.5 mL/min/1.73 m~2~. Saran et al. reported the percentage of patients having an nPNA less than 0.8 in the weekly Kt/Vurea\>2.0 group (13.6%) was significantly lower than in the weekly Kt/Vurea \<2.0 group (66.7%), and suggested a weekly Kt/Vurea\<2.0 as an objective index for the initiatione of RRT^[@b20-kjim-19-2-81-2])^. Also, Kim et al. recommended a weekly Kt/Vurea\<1.5 or nPNA \<0.8 g/kg/day as an objective index for the initiation of RRT in Korean subjects as a Korean's standard weight was considered lower than that of Westerner subjects^[@b21-kjim-19-2-81-2])^. The present study has shown that a *KP index* \<2.0 is an objective index for the initiation of RRT in Koreans. Ikizler et al. reported a good correlation between the residual renal function and the nutritional index, with the nutritional indices, including protein intake, decreased in relation to the decrease in the creatinine clearance rate^[@b22-kjim-19-2-81-2])^. Park et al. described a positive correlation between the creatinine clearance and the Kt/Vurea with the nPNA^[@b6-kjim-19-2-81-2])^. Our study also showed a good correlation between the Kt/Vurea and nPNA ([Figure 2](#f2-kjim-19-2-81-2){ref-type="fig"}). Kim et al. demonstrated the renal function index to be closely correlated with the protein intake and nutritional status in pre-dialysis patients, and, with a declining small solute clearance, protein intake and nutritional status became worse^[@b21-kjim-19-2-81-2])^. They also commented that the mathematical coupling between the weekly Kt/Vurea and the nPNA was possible because the two indices were calculated from the urea nitrogen levels. Our formulated *KP index*, using the above two clinically useful and objective indices, could be used to determine the best time to initiate RRT in patients with ESRD. The KP of the *KP index* was symbolically composed of the K from the weekly Kt/Vurea and the P from the nPNA.

In this study, a significant correlation was found between the *KP index* and the weekly Kt/Vurea, RRF, Ccr, nPNA, %LBM and the FFEFBM. Therefore, the *KP index* is a clinically useful index reflecting the renal function and nutritional status of patients with ESRD. There was no significance in the incidence of RRT between the 1.5\<Kt/Vurea \<2.0 (25.0%) and 2.0\<Kt/Vurea \<2.5 (9.4%) groups. However, the incidence of RRT in the 1.5\<*KP index* \<2.0 group (43.6%) was significantly higher than in the 2.0\<*KP index* \<2.5 group (13.6%). So, the *KP index* is considered a more objective index for ESRD patients in the determinatione of the appropriate time to initiate RRT.

Patients with CRF have to be continuously treated and regularly tested by a nephrologist. Starting dialysis at the most suitable time in ESRD patients apparently improves the patient's prognosis.

There were some limitations to this study. First, an error by the patient or nephrologist in deciding when to initiate RRT could not be perfectly excluded. Second, comparative analyses between many variable factors, including accompanying diseases, physical activity, medicine history and economical status, were not achieved. Third, there is a need to prove the clinical usefulness of the *KP index* using a long-term follow-up on patients with ESRD through the observation of the close relevant relation between the *KP index* and the survival rate by long-term research. Fourth, the *KP index* was simply designed from the weekly Kt/Vurea and nPNA, and a relationship between these two indices has often been attributed to mathematical coupling. The mathematical coupling undoubtedly contributed to the strength of the correlation between the nPNA and the weekly Kt/Vurea, as the urinary urea concentration was an important joint variable in these two parameters^[@b23-kjim-19-2-81-2],\ [@b24-kjim-19-2-81-2])^. So, there is a need for further research to more accurately prove the interrelation between these two indices.

In conclusion, the *KP index* is considered a clinically useful index for determining the appropriate time to initiate RRT in patients with ESRD. The timing should also be fixed with regard to the various other indices and clinical features for a desirable prognosis of such patients. In addition, further studies will be required to determine accurate guidelines for the appropriate time for the initiation of RRT.
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###### 

Clinical and laboratory data of the all patients

  ------------------------------- ---------------
  Number (patients)               186
  Age (years)                     56.1±14.7
  Male:Female                     94:92
  Serum albumin (g/dL)            3.24±0.86
  Serum creatinine (mg/dL)        6.67±3.40
  Weekly Kt/Vurea                 1.61±0.74
  Weekly Ccr (L/week/1.73 m^2^)   73.89±48.19
  RRF (mL/min)                    6.42±3.49
  nPNA (g/kg/day)                 0.92±0.30
  FFEFBM (kg)                     25.68±9.31
  \% LBM (%)                      45.9±13.2
  Curea (mL/min)                  5.15±2.66
  Ccr (mL/min/1.73 m^2^)          7.31±4.80
  UPRT (mg/day)                   2970.1±2826.3
  *KP index*                      1.95±0.67
  ------------------------------- ---------------

###### 

Comparison of indices according to *KP index* in the patients with weekly Kt/Vurea index between 1.0 and 2.0

  ----------------------------------------------------------------------
                         *KP index*\       *KP index*\       *p* value
                         \< 2.0 group      \>2.0 group       
  ---------------------- ----------------- ----------------- -----------
  Number                 54                37                

  Age (years)            54.5±16.7         55.9±13.8         NS

  Serum albumin (g/dL)   3.17±0.76         3.24±0.92         NS

  Serum Cr (mg/dL)       6.44±2.83         7.12±2.05         NS

  Weekly Kt/Vurea        1.37±0.24         1.71±0.20         \<0.001

  RRF (mL/min)           6.64±4.99         6.50±2.05         NS

  nPNA (g/kg/day)        0.79±0.15         1.12±0.20         \<0.001

  FFEFBM (kg)            26.25±8.62        29.41±9.18        NS

  \% LBM (%)             44.7±10.6         54.0±11.1         \<0.001

  UPRT (mg/day)          3947.59±3743.20   3252.73±3122.10   NS
  ----------------------------------------------------------------------

###### 

Comparison of frequency of RRT according to *KP index* in the patients with weekly Kt/Vurea index between 1.0 and 2.0

                          RRT          Non-RRT   Total (number)
  ----------------------- ------------ --------- ----------------
  *KP index*\<2.0 group   26 (48.2%)   28        54
  *KP index*\>2.0 group   7 (18.9%)    30        37

###### 

Correlation matrix for indices of renal function, protein intake and nutritional status in the all patients

             *KP index*   Kt/Vurea    RRF         Ccr         nPNA        \% LBM      FFEFBM
  ---------- ------------ ----------- ----------- ----------- ----------- ----------- --------
  Kt/Vurea   0.896^\*^                                                                
  RRF        0.681^\*^    0.833^\*^                                                   
  Ccr        0.520^\*^    0.680^\*^   0.967^\*^                                       
  nPNA       0.896^\*^    0.605^\*^   0.387^\*^   0.254^\*^                           
  %LBM       0.626^\*^    0.480^\*^   0.496^\*^   0.463^\*^   0.642^\*^               
  FFEFBM     0.485^\*^    0.422^\*^   0.576^\*^   0.588^\*^   0.447^\*^   0.871^\*^   
  sAlbumin   0.070        0.131       0.141       0.147       −0.005      0.113       0.088

###### 

Comparison of incidence of RRT according to Kt/Vurea

                                    RRT          Non-RRT   Total (number)
  --------------------------------- ------------ --------- ----------------
  1.5\<Weekly Kt/Vurea\<2.0 group   11 (25.0%)   33        44
  2.0\<Weekly Kt/Vurea\<2.5 group   3 (9.4%)     29        32

###### 

Comparison of incidence of RRT According to *KP index*

                                RRT          Non-RRT   Total (number)
  ----------------------------- ------------ --------- ----------------
  1.5 \<*KP index*\<2.0 group   24 (43.6%)   31        55
  2.0 \<*KP index*\<2.5 group   8 (13.6%)    51        59
